Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery"

MeSH terms

• Antifibrinolytic Agents / therapeutic use
• Biomarkers
• Blood Transfusion / statistics & numerical data*
• Cardiac Surgical Procedures*
• Cardiopulmonary Bypass / statistics & numerical data
• Combined Modality Therapy
• Confounding Factors, Epidemiologic
• Factor VIIa / therapeutic use*
• Hemostatics / therapeutic use*
• Humans
• Plasma
• Platelet Transfusion / statistics & numerical data
• Postoperative Hemorrhage / drug therapy*
• Postoperative Hemorrhage / therapy
• Randomized Controlled Trials as Topic / methods*
• Randomized Controlled Trials as Topic / statistics & numerical data
• Recombinant Proteins / therapeutic use
• Reoperation / statistics & numerical data
• Research Design